Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03888014 · ClinicalTrials.gov registry record
Intraoperative Fluorescence With Augmented Reality
A clinical trial, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 7
- Enrollment target
NCT03888014: Completed study, sponsored by Cedars-Sinai Medical Center.
NCT03888014 is a clinical trial that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03888014 has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This is a study looking at a new way to evaluate vascular problems or tumors in brain surgery patients using a standard \& approved intravenous dye and augmented reality.
Primary Outcome
Surgeon assessment of Glow800 compared to ICG-VA in usefulness
Interventions
- DRUG indocyanine green (ICG)
- DEVICE GLOW800
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2021-06-01 |
What the finished NCT03888014 record still lists
NCT03888014 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which indocyanine green (ICG) is the first listed.
NCT03888014 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03888014 about?
NCT03888014 is a clinical study titled "Intraoperative Fluorescence With Augmented Reality". This is a study looking at a new way to evaluate vascular problems or tumors in brain surgery patients using a standard \& approved intravenous dye and augmented reality.
What is the current status of trial NCT03888014?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2019-07-01. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT03888014?
The interventions under investigation include: indocyanine green (ICG) (DRUG), GLOW800 (DEVICE).
Who is sponsoring clinical trial NCT03888014?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI